메뉴 건너뛰기




Volumn 131, Issue 1, 2016, Pages 9-16

Drug-resistant MS spasticity treatment with Sativex® add-on and driving ability

Author keywords

Computerized test battery; Driving ability; MS spasticity; Tetrahydrocannabinol cannabidiol

Indexed keywords

NABIXIMOLS; PLANT EXTRACT; TETRAHYDROCANNABINOL-CANNABIDIOL COMBINATION;

EID: 84919959419     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/ane.12287     Document Type: Article
Times cited : (29)

References (31)
  • 1
    • 33746588738 scopus 로고    scopus 로고
    • The epidemiology of multiple sclerosis in Europe
    • Pugliatti M, Rosati G, Carton H et al. The epidemiology of multiple sclerosis in Europe. Eur J Neurol 2006;13:700-22.
    • (2006) Eur J Neurol , vol.13 , pp. 700-722
    • Pugliatti, M.1    Rosati, G.2    Carton, H.3
  • 2
    • 84888352123 scopus 로고    scopus 로고
    • Natural history of multiple sclerosis symptoms
    • Kister I, Bacon TE, Chamot E et al. Natural history of multiple sclerosis symptoms. Int J MS Care 2013;15:146-58.
    • (2013) Int J MS Care , vol.15 , pp. 146-158
    • Kister, I.1    Bacon, T.E.2    Chamot, E.3
  • 3
    • 4444288689 scopus 로고    scopus 로고
    • Prevalence and treatment of spasticity reported by multiple sclerosis patients
    • Rizzo MA, Hadjimichael OC, Preiningerova J, Vollmer TL. Prevalence and treatment of spasticity reported by multiple sclerosis patients. Mult Scler 2004;10:589-95.
    • (2004) Mult Scler , vol.10 , pp. 589-595
    • Rizzo, M.A.1    Hadjimichael, O.C.2    Preiningerova, J.3    Vollmer, T.L.4
  • 4
    • 84867255279 scopus 로고    scopus 로고
    • Treatment of spasticity in multiple sclerosis: new perspectives regarding the use of cannabinoids
    • Oreja-Guevara C. Treatment of spasticity in multiple sclerosis: new perspectives regarding the use of cannabinoids. Rev Neurol 2012;55:421-30.
    • (2012) Rev Neurol , vol.55 , pp. 421-430
    • Oreja-Guevara, C.1
  • 5
    • 84893105135 scopus 로고    scopus 로고
    • Spasticity in patients with multiple sclerosis-clinical characteristics, treatment and quality of life
    • Flachenecker P, Henze T, Zettl UK. Spasticity in patients with multiple sclerosis-clinical characteristics, treatment and quality of life. Acta Neurol Scand 2014;129:154-62.
    • (2014) Acta Neurol Scand , vol.129 , pp. 154-162
    • Flachenecker, P.1    Henze, T.2    Zettl, U.K.3
  • 7
    • 33847766180 scopus 로고    scopus 로고
    • Randomized controlled trial of cannabis-based medicine in spasticity caused by multiple sclerosis
    • Collin C, Davies P, Mutiboko IK, Ratcliff S. Randomized controlled trial of cannabis-based medicine in spasticity caused by multiple sclerosis. Eur J Neurol 2007;14:290-6.
    • (2007) Eur J Neurol , vol.14 , pp. 290-296
    • Collin, C.1    Davies, P.2    Mutiboko, I.K.3    Ratcliff, S.4
  • 8
    • 77952835462 scopus 로고    scopus 로고
    • ®, in subjects with symptoms of spasticity due to multiple sclerosis
    • ®, in subjects with symptoms of spasticity due to multiple sclerosis. Neurol Res 2010;32:451-9.
    • (2010) Neurol Res , vol.32 , pp. 451-459
    • Collin, C.1    Ehler, E.2    Waberzinek, G.3
  • 9
    • 79953822342 scopus 로고    scopus 로고
    • ®®), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis
    • ®®), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis. Eur J Neurol 2011;18:1122-31.
    • (2011) Eur J Neurol , vol.18 , pp. 1122-1131
    • Novotna, A.1    Mares, J.2    Ratcliffe, S.3
  • 10
    • 33745025055 scopus 로고    scopus 로고
    • Long-term use of a cannabis-based medicine in the treatment of spasticity and other symptoms in multiple sclerosis
    • Wade DT, Makela PM, House H, Batman C, Robson P. Long-term use of a cannabis-based medicine in the treatment of spasticity and other symptoms in multiple sclerosis. Mult Scler 2006;12:639-45.
    • (2006) Mult Scler , vol.12 , pp. 639-645
    • Wade, D.T.1    Makela, P.M.2    House, H.3    Batman, C.4    Robson, P.5
  • 11
    • 84867112015 scopus 로고    scopus 로고
    • ®®) in people with multiple sclerosis: a new approach
    • ®®) in people with multiple sclerosis: a new approach. Trials 2012;13:189.
    • (2012) Trials , vol.13 , pp. 189
    • Wright, S.1    Duncombe, P.2    Altman, D.G.3
  • 13
    • 84872287267 scopus 로고    scopus 로고
    • ® long-term use: an open-label trial in patients with spasticity due to multiple sclerosis
    • ® long-term use: an open-label trial in patients with spasticity due to multiple sclerosis. J Neurol 2013;260:285-95.
    • (2013) J Neurol , vol.260 , pp. 285-295
    • Serpell, M.G.1    Notcutt, W.2    Collin, C.3
  • 14
    • 84884180640 scopus 로고    scopus 로고
    • Review of the novelties presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (II)
    • Fernandez O, Arnal-Garcia C, Arroyo-Gonzalez R et al. Review of the novelties presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (II). Rev Neurol 2013;57:269-81.
    • (2013) Rev Neurol , vol.57 , pp. 269-281
    • Fernandez, O.1    Arnal-Garcia, C.2    Arroyo-Gonzalez, R.3
  • 15
    • 46049119745 scopus 로고    scopus 로고
    • Adverse effects of medical cannabinoids: a systematic review
    • Wang T, Collet J, Shapiro S, Ware MA. Adverse effects of medical cannabinoids: a systematic review. CMAJ 2008;178:1669-78.
    • (2008) CMAJ , vol.178 , pp. 1669-1678
    • Wang, T.1    Collet, J.2    Shapiro, S.3    Ware, M.A.4
  • 18
    • 77953796878 scopus 로고    scopus 로고
    • ® (nabiximols), on spasticity in people with multiple sclerosis
    • ® (nabiximols), on spasticity in people with multiple sclerosis. Mult Scler 2010;16:707-14.
    • (2010) Mult Scler , vol.16 , pp. 707-714
    • Wade, D.T.1    Collin, C.2    Stott, C.3    Duncome, P.4
  • 19
    • 84873393356 scopus 로고    scopus 로고
    • Endocannabinoid system modulator use in everyday clinical practice in the UK and Spain
    • Garcia-Merino A. Endocannabinoid system modulator use in everyday clinical practice in the UK and Spain. Expert Rev Neurother 2013;13(3 Suppl 1):9-13.
    • (2013) Expert Rev Neurother , vol.13 , Issue.3 , pp. 9-13
    • Garcia-Merino, A.1
  • 20
    • 0021035886 scopus 로고
    • Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)
    • Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444-52.
    • (1983) Neurology , vol.33 , pp. 1444-1452
    • Kurtzke, J.F.1
  • 21
    • 44849131341 scopus 로고    scopus 로고
    • Validity, reliability, and clinical importance of change in a 0-10 numeric rating scale measure of spasticity: a post hoc analysis of a randomized, double-blind, placebo-controlled trial
    • Farrar JT, Troxel AB, Stott C, Dunconmbe B, Jensen MP. Validity, reliability, and clinical importance of change in a 0-10 numeric rating scale measure of spasticity: a post hoc analysis of a randomized, double-blind, placebo-controlled trial. Clin Ther 2008;30:974-85. http://www.sciencedirect.com/science/article/pii/S0149291808001811.
    • (2008) Clin Ther , vol.30 , pp. 974-985
    • Farrar, J.T.1    Troxel, A.B.2    Stott, C.3    Dunconmbe, B.4    Jensen, M.P.5
  • 22
    • 0026333617 scopus 로고
    • A new method for measuring daytime sleepiness: the Epworth sleepiness scale
    • Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991;14:540-5.
    • (1991) Sleep , vol.14 , pp. 540-545
    • Johns, M.W.1
  • 25
    • 84977787651 scopus 로고    scopus 로고
    • A survey of advice on driving in neurological conditions amongst neurologists and neurosurgeons
    • Wong SL, Sharrack B. A survey of advice on driving in neurological conditions amongst neurologists and neurosurgeons. J Neurol Neurosurg Psychiatry 2013;84:e2.
    • (2013) J Neurol Neurosurg Psychiatry , vol.84 , pp. e2
    • Wong, S.L.1    Sharrack, B.2
  • 26
    • 84879924024 scopus 로고    scopus 로고
    • Driving performance in persons with mild to moderate symptoms of multiple sclerosis
    • Devos H, Brijs T, Alders G, Wets G, Feys P. Driving performance in persons with mild to moderate symptoms of multiple sclerosis. Disabil Rehabil 2013;35:1387-93.
    • (2013) Disabil Rehabil , vol.35 , pp. 1387-1393
    • Devos, H.1    Brijs, T.2    Alders, G.3    Wets, G.4    Feys, P.5
  • 27
    • 49949092721 scopus 로고    scopus 로고
    • The contribution of cognition and spasticity to driving performance in multiple sclerosis
    • Marcotte TD, Rosenthal TJ, Roberts E et al. The contribution of cognition and spasticity to driving performance in multiple sclerosis. Arch Phys Med Rehabil 2008;89:1753-8.
    • (2008) Arch Phys Med Rehabil , vol.89 , pp. 1753-1758
    • Marcotte, T.D.1    Rosenthal, T.J.2    Roberts, E.3
  • 28
    • 84874353280 scopus 로고    scopus 로고
    • Predictors of driving in individuals with relapsing-remitting multiple sclerosis
    • Akinwuntan AE, Devos H, Stepleman L et al. Predictors of driving in individuals with relapsing-remitting multiple sclerosis. Mult Scler 2013;19:344-50.
    • (2013) Mult Scler , vol.19 , pp. 344-350
    • Akinwuntan, A.E.1    Devos, H.2    Stepleman, L.3
  • 29
    • 42149124914 scopus 로고    scopus 로고
    • Cognitive abilities as predictors of safety to drive in people with multiple sclerosis
    • Lincoln NB, Radford KA. Cognitive abilities as predictors of safety to drive in people with multiple sclerosis. Mult Scler 2008;14:123-8.
    • (2008) Mult Scler , vol.14 , pp. 123-128
    • Lincoln, N.B.1    Radford, K.A.2
  • 30
    • 77949293828 scopus 로고    scopus 로고
    • Examining the relationship between cognition and driving performance in multiple sclerosis
    • Schultheis MT, Weisser V, Ang J et al. Examining the relationship between cognition and driving performance in multiple sclerosis. Arch Phys Med Rehabil 2010;91:465-73.
    • (2010) Arch Phys Med Rehabil , vol.91 , pp. 465-473
    • Schultheis, M.T.1    Weisser, V.2    Ang, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.